175 related articles for article (PubMed ID: 6487516)
1. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.
Ramu A; Spanier R; Rahamimoff H; Fuks Z
Br J Cancer; 1984 Oct; 50(4):501-7. PubMed ID: 6487516
[TBL] [Abstract][Full Text] [Related]
2. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone.
Chitnis MP; Kamath NS
Oncology; 1987; 44(1):47-50. PubMed ID: 3561929
[TBL] [Abstract][Full Text] [Related]
3. 5'-Nucleotidase activity and arachidonate metabolism in doxorubicin sensitive and resistant P388 cells.
Ramu A; Glaubiger D; Soprey P; Reaman GH; Feuerstein N
Br J Cancer; 1984 Apr; 49(4):447-51. PubMed ID: 6324840
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity to anthracyclines in P388/dx leukaemia cells.
Bossa R; Dasdia T; Galatulas I; Zunino F
Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
[TBL] [Abstract][Full Text] [Related]
5. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.
Streeter DG; Johl JS; Gordon GR; Peters JH
Cancer Chemother Pharmacol; 1986; 16(3):247-52. PubMed ID: 3457646
[TBL] [Abstract][Full Text] [Related]
6. Membrane transport changes in an adriamycin-resistant murine leukemia cell line and in its sensitive parental cell line.
Bose R; Lam HY
Cancer Chemother Pharmacol; 1988; 21(1):14-8. PubMed ID: 3342461
[TBL] [Abstract][Full Text] [Related]
7. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
Ramu A; Glaubiger D; Weintraub H
Cancer Treat Rep; 1984 Apr; 68(4):637-41. PubMed ID: 6713419
[TBL] [Abstract][Full Text] [Related]
8. Exploring multidrug resistance using rhodamine 123.
Kessel D
Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
[TBL] [Abstract][Full Text] [Related]
9. Modulation of in vitro response to adriamycin by verapamil in murine P388 leukaemia, Ehrlich ascites carcinoma and sarcoma 180.
Pradhan SG; Chitnis MP; Basrur VS; Tantri SK
Eur J Cancer Clin Oncol; 1987 Apr; 23(4):437-42. PubMed ID: 3609108
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
Hait WN; Pierson NR
Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
[TBL] [Abstract][Full Text] [Related]
11. Cell surface alterations in murine leukaemia P388 adriamycin-resistant cells: studies on lectin-induced agglutination and rearrangement of lectin receptors.
Basrur VS; Chitnis MP; Menon RS
Oncology; 1985; 42(5):328-31. PubMed ID: 4034147
[TBL] [Abstract][Full Text] [Related]
12. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
Nair S; Samy TS; Krishan A
Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
[TBL] [Abstract][Full Text] [Related]
13. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
Ganapathi R; Reiter W; Krishan A
J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267
[TBL] [Abstract][Full Text] [Related]
14. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
Ramu A; Glaubiger D; Fuks Z
Cancer Res; 1984 Oct; 44(10):4392-5. PubMed ID: 6467200
[TBL] [Abstract][Full Text] [Related]
15. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
Ramu A; Cohen L; Glaubiger D
Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
[TBL] [Abstract][Full Text] [Related]
16. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
[TBL] [Abstract][Full Text] [Related]
18. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
Ramu A; Fuks Z; Gatt S; Glaubiger D
Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
[TBL] [Abstract][Full Text] [Related]
19. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
Kessel D; Wilberding C
Cancer Treat Rep; 1985 Jun; 69(6):673-6. PubMed ID: 4016770
[TBL] [Abstract][Full Text] [Related]
20. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
Adwankar MK; Chitnis MP
Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
